Health
NCDC Issues Public Health Advisory On Human Metapneumovirus (HMPV)
There is no specific antiviral treatment or vaccine for HMPV.

The Nigeria Centre for Disease Control and Prevention (NCDC) has issued the following Public Health Advisory on Human Metapneumovirus (HMPV) Awareness, Preparedness, and Prevention.
The document released by, Dr. Jide Idris, the Director – GeneralNigeria Centre for Disease Control and Prevention, said :
” NCDC is committed to safeguarding the health of all Nigerians. In response to recent reports of increased Human Metapneumovirus (HMPV) activity in China and other affected regions, as well as growing public interest in the matter, the NCDC in collaboration with the Federal Ministry of Health and Social Welfare is closely monitoring global developments.
We aim to provide timely, accurate information and guidance to keep the Nigerian public informed and prepared. Global situation update.
It is important to note that the rumor circulating about the World Health Organization (WHO) declaring HMPV a Public Health Emergency of International Concern (PHEIC) is false and should be disregarded.
The WHO has not made such a declaration. Recent reports indicate a significant rise in Human Metapneumovirus (HMPV) cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France, and Germany, particularly during the winter season.
The UK Health Security Agency (UKHSA) has highlighted a notable rise in hospital admissions due to HMPV-related complications, especially among children under five and older adults in care homes.
This trend emphasizes the need for heightened preparedness and vigilance.
Current Situation in Nigeria
Nigeria operates a National Influenza Sentinel Surveillance (NISS) system, comprising sentinel sites distributed across the six geopolitical zones of the country.
These sites, which include tertiary and secondary health facilities, monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).
As of January 6, 2025, data from this surveillance system does not indicate any unusual increase in respiratory infections, including those caused by Human Metapneumovirus (HMPV).
However, given the global trends in HMPV cases, the Nigeria Centre for Disease Control and Prevention (NCDC) is proactively implementing measures to strengthen the country’s preparedness and response capacity.
NCDC Preparedness Measures
The NCDC is closely monitoring the situation and has implemented the following actions to ensure public health safety:
1. Dynamic Risk Assessment
On January 6, 2025, the Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA), conducted a dynamic risk assessment for Human Metapneumovirus (HMPV).
The assessment classified the risk of HMPV for Nigeria as moderate.
This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts.
2. Public Health Advisory:
Issued this advisory to provide Nigerians with up-to-date information on preparedness actions and preventive measures.
3. Point of Entry (POE):
The Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with Port Health Authorities, is taking proactive steps to ensure robust preparedness at all international points of entry (PoEs) in response to the dynamic risk assessment for Human Metapneumovirus (HMPV).
These measures are designed to mitigate the potential risk of HMPV transmission through international travel. Key actions include
▪︎ Conducting a comprehensive situation analysis at all international PoEs to assess current readiness levels.
▪︎ An Entry Implementation Protocol on HMPV, approved by the Honourable Minister of Health and Social Welfare, is being developed and will be distributed to all points of entry to guide response activities.
▪︎ In addition, quarantine facilities are being identified and prepared to manage any suspected or confirmed cases if required.
▪︎ Infection Prevention and Control (IPC) materials are being deployed to PoEs to ensure adherence to hygiene and safety protocols.
▪︎ Information, Education, and Communication (IEC) materials are being developed and distributed to raise awareness and provide clear guidelines for frontline staff and travelers at PoEs.
4. Enhanced Surveillance and Laboratory Diagnosis:
The National Influenza Sentinel Surveillance (NISS) sites across the six geopolitical zones monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).
This platform, which is already testing for COVID-19, will now also start testing for HMPV. Provisions will be made to increase the number of tests conducted.
Additionally, laboratories in states with international airports will be supported to enable them to test for HMPV.
5. Infection Prevention and Control (IPC):
Advisories have been issued to hospitals nationwide on enhanced IPC practices, including proper hand hygiene, environmental cleaning, respiratory hygiene, and cough etiquette.
All health facilities are required to identify an appropriate isolation room where cases can be quickly isolated while receiving care.
6. Case Management Preparedness:
Collaborating with state governments and healthcare facilities to provide training for healthcare workers to ensure adequate case management teams are in place and ready to respond if needed.
This will ensure that healthcare workers are able to provide appropriate care and maintain a high index of suspicion. Supportive care and an emphasis on a high index of suspicion are crucial.
We are requesting state governments to activate their treatment centers or isolation centers to ensure they are prepared to manage cases appropriately.
7. Stockpiling of Medical Countermeasures:
Relevant materials such as PPEs (face masks, hand gloves, hand hygiene supplies, and other essential IPC items) have been stockpiled for rapid deployment if required.
Additionally, laboratory consumables, reagents, and other necessary supplies have also been stockpiled to ensure readiness.
Risk Communication and Community Engagement:Engaging with the public through clear and accurate messages to address concerns, dispel misinformation, and encourage appropriate health-seeking behaviors.
We work in close collaboration with state risk communication and community engagement pillars, health educators, and other trusted voices, such as the media.
These efforts reflect NCDC’s commitment to proactive coordination and response at all levels of public health.
Public Advisory What is HMPV?
Human Metapneumovirus (HMPV) is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in:
• Young children •
Older adults
• Individuals with weakened immune systems
There is no specific antiviral treatment or vaccine for HMPV.
Supportive care, such as rest, hydration, and fever management, remains the primary approach to recovery.
Symptoms
• Cough
• Fever
• Nasal congestion
• Shortness of breath
• Wheezing
• Bronchitis or pneumonia (in vulnerable populations such as very young children, older people, patients with low immunity such and those on cancer treatment, uncontrolled diabetes etc).
The incubation period is 3-5 days after exposure, and infections typically resolve within 2-5 days with supportive care.
We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.
However, high-risk populations may experience complications.
Transmission HMPV spreads through:
• Respiratory droplets from coughing and sneezing
• Close personal contact (e.g., touching or shaking hands)
• Touching contaminated surfaces and then touching the face.
Overcrowding and poor ventilation can lead to increased transmission, e.g., in congregate settings such as correctional centers and poorly managed IDPs.
Preventive Measures
To reduce the risk of HMPV infection, the public is advised to follow these preventive steps:
For the General Public:
• Hand Hygiene: Wash hands frequently with soap and water for at least 20 seconds.
• Respiratory Etiquette: Cover your mouth and nose with a tissue or elbow when coughing or sneezing. Cover your mouth an nose with face mask if you are experiencing flu like symptoms.
• Avoid Close Contact: Maintain distance from individuals showing symptoms of respiratory illness.
• Avoid overcrowded places.
• Disinfect Surfaces: Regularly clean and disinfect frequently touched objects and surfaces.
• Self-Isolation: Stay home if experiencing symptoms to prevent spreading the virus. As is correct parctice and seek medical care from appropriate sources.
Protecting Vulnerable Groups:
• Young children, older adults, and individuals with underlying health conditions such as people with chronic diseases such as diabetes, on cancer treatment, immunicompromised paients or those with low immunity should seek prompt medical attention if experiencing severe symptoms. Healthcare Guidance
For Healthcare Workers:
• Reinforce Infection Prevention and Control (IPC) measures in healthcare facilities.
• Enhance surveillance for acute respiratory infections and report unusual increases to the relevant authorities. Index of suspiciona nd enhanced
• Use appropriate PPE when attending to patients with respiratory symptoms.
• Educate patients on preventive measures and when to seek emergency medical care.
• Provide symptomatic care and promptly refer severe cases to specialist facilities.
Conclusion
The NCDC remains dedicated to protecting the health of Nigerians through continuous surveillance and prompt response to infectious diseases.
We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.
We also emphasize the importance of relying on verified information from the NCDC and WHO.
For emergencies, please contact the NCDC’s toll-free line at 6232 or email us at info@ncdc.gov.ng.
Follow us on our verified social media platforms for timely updates.
Together, we can protect our communities from respiratory infections and ensure a healthier Nigeria.
Contact Information • Toll-Free Number: 6232 • SMS: *** • WhatsApp: *** • Twitter: @NCDCGov • Facebook: @NCDCgov • Instagram: @NCDCgov
Health
JUST IN: Ogun confirms Lassa fever outbreak as NYSC member dies

A 25-year-old member of the National Youth Service Corp (NYSC), has reportedly died of Lassa fever at a secondary health facility in ljebu North Local Government Area of Ogun State.
It wwas learnt that the female corp member who fell sick while in Ondo State, was brought to the health facility last Tuesday and later died same day.
This was contained in a statement signed by the Commissioner for Health, Tomi Coker, on Wednesday.
Coker also confirmed the outbreak of Lassa fever in the state.
The statement reads, “Ogun State has confirmed a case of Lassa Fever and as such declared Lassa fever outbreak.
“The index case is a 25-year-old female National Youth Corp member who fell sick while in Ondo State and was brought to on of our secondary health facility in ljebu North LGA on 18th March 2025 and later died same day.
“ Lassa fever is a viral Haemorrhagic disease that presents with High grade fever, Headache, General body weakness, Sore throat, Muscle pain, Cough, Nausea, Vomiting, Diarrhoea, Chest pain and Unexplained bleeding from the ears, eyes, nose, mouth and other body openings.
”Coker urged members of the community to report to the hospital if any of the listed symptoms is noticed.
“We implore members of the community to promptly report to the hospital if they notice any of these symptoms.
Any case of febrile illness that has not responded to 48 hours use of anti-malaria or antibiotics should raise an index of suspicion for Lassa fever!
“We implore all Health facilities in Ogun State, public and private, to step up Infection Prevention and Control measures and to encourage compliance by all health facility staff.“
Healthcare worker that suspects Lassa fever in a patient, are advised to call their local government disease surveillance and notification officer (LGA DSNO) whose numbers are placed in our health facilities or call State Disease surveillance and Notification Officer (0703-421-4893) or State Epidemiologist (0808-425-0881),” she added.
The commissioner, however reiterated the Governor Dapo Abiodun-led administration’s dedication to protecting the health of the citizens through continuous surveillance and prompt response to infectious diseases.
She added that the ministry in collaboration with the Rapid Response Team at ljebu North East is keeping the situation under control with enhanced surveillance and community engagement and mobilization for effective response.
Health
JUST IN: NAFDAC goes digital in fight against fake pharmaceutical products

The National Agency for Food and Drug Administration and Control, NAFDAC, has gone digital in its efforts to rid the country of substandard and falsified pharmaceutical products.
During a two-day workshop and training session in Port Harcourt, Rivers State, on Wednesday, NAFDAC introduced an app, Greenbook, an online platform for identifying the source of a product.
The Greenbook allows consumers to enter the product name, brand name, or registration number to search for information about its registration status.
If the product is listed in the Greenbook, it signifies that it has been registered by NAFDAC and is considered authentic.
The app serves as a tool to help consumers identify and avoid potentially fake or substandard products.
The Director-General of NAFDAC, Prof. Mojisola Adeyeye, speaking at the workshop in Port Harcourt, stated that these fake products are “produced by our greedy businessmen and their international collaborators to get rich or make money,” describing it as the worst form of inhumanity of man to his fellow men.
Prof. Adeyeye, who was represented by the Director of the Post-Marketing Surveillance Directorate, NAFDAC, Fraden Bitrus, noted that the agency has, over the years, deployed various measures to combat falsified products.
She expressed concern that counterfeiters have adopted increasingly sophisticated methods to advance their trade but assured that NAFDAC “is poised to use technologies and modern means to mitigate the activities of counterfeiters, hence the need for stakeholder sensitisation.”
She added that the workshop aims to educate stakeholders and provide hands-on training on the NAFDAC Greenbook, the Traceability Regulation 2024, and the Paediatric Regulation 2024, ensuring that both the regulator and the regulated are aligned in the fight against substandard and falsified medical products.
Prof. Adeyeye revealed that the project is being implemented in phases, initially used for COVID-19 vaccine distribution as a pilot project, which yielded highly effective results.
She noted, “Within 24 hours, batches of substandard or defective vaccines distributed in the country were traced and recalled.”
She further stated, “We have implemented it for commodities in public health, such as antimalarial and narcotic products.
Over time, we will extend it to other products. Please note that with this technology, stakeholders can detect and reject SF products before they enter the supply chain.”
She called on all stakeholders in the healthcare sector to support these initiatives to combat fake products and ensure the availability of quality, safe, and efficacious medical products for the people of Nigeria.
Health
IPOB to NAFDAC: Return seized goods from Onitsha drug market

The Indigenous People of Biafra (IPOB) has called on the National Agency for Food and Drug Administration and Control (NAFDAC) to return goods seized from traders at Ogbo Ogwu Drug Market in Onitsha, Anambra State.
In a statement issued by IPOB’s Media and Publicity Secretary, Comrade Emma Powerful, the group alleged that NAFDAC officials conducted a midnight raid on the market, blocking CCTV cameras, breaking into shops, and confiscating goods under the claim of targeting fake drugs.
IPOB criticized the method of the operation, questioning the agency’s approach and transparency.
While IPOB reaffirmed its stance against the sale of counterfeit drugs, it raised concerns over the alleged seizure of traders’ goods in their absence, the blocking of surveillance cameras, and the lack of evidence proving that all confiscated products were counterfeit.
The group posed several questions to NAFDAC, including: Why was the operation conducted at midnight? Why were CCTV cameras blocked?
Where is the evidence that the confiscated drugs were fake? Why was the entire market sealed, affecting both innocent and guilty traders?
IPOB urged NAFDAC to adopt a more professional and transparent approach to combating fake drugs, suggesting that the agency establish permanent offices in drug markets to ensure proper regulation rather than conducting surprise raids.
The statement also called for collaboration between NAFDAC and the Anambra State Government to relocate the drug market to the new Oba Drug Market, ensuring that only licensed and certified dealers are allowed to operate.
-
Crime3 days ago
BREAKING: Many feared dead as suspected herdsmen attack Benue community
-
Business2 days ago
EFCC and Interpol Hunt for CBEX fraudsters
-
Business2 days ago
FIRS Targets N25.2tr Revenue in 2025
-
Sports2 days ago
Ex-Man Utd star Bastian Schweinsteiger ‘splits from wife’
-
News2 days ago
Sanwo-Olu Opens Lagos State Commercial Court
-
International2 days ago
UK Supreme Court rules definition of ‘woman’ based on sex at birth and not by transgender
-
Business2 days ago
Top Ten Ponzi Schemes That Have Stolen From Nigerians
-
News2 days ago
Kogi Govt Applauds President Tinubu for Appointments of Indigenes to Strategic National Roles